Gemcitabine combinations vs gemcitabine
Overall survival ‐ Gemcitabine plus other agent(s) · advanced pancreatic cancer
Gemcitabine combinations showed no clear difference in overall survival ‐ Gemcitabine plus other agent(s) compared with gemcitabine alone (low certainty).
1 finding from 1 review
- HR 0.79 [0.56, 1.1]4 studies · 767 participantsLow